CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop targeted therapies for glioblastoma by investigating the role of microglial cells in the tumor microenvironment. It focuses on selectively inhibiting autophagy in these cells to restore immune responses against tumors, potentially leading to new treatment options.
Glioblastoma is a highly aggressive type of brain cancer that kills around 15,000 people per year in Europe alone.
It also has a devastating effect on patients' quality of life.
Therefore, the clinical need in glioblastoma management is one of the highest in oncology: effective treatments are dearly needed.
Over the past decade, the brain tissue surrounding glioblastoma tumors has been intensively studied.
In this so-called 'tumor microenvironment' (TME), microglial cells make up the bulk cell t…
UNIVERSITEIT ANTWERPEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
